Drugs / Bone Bioactive Liquid
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT06587880 Comparator | Aug 2025 → Dec 2026 expected | alveolar periostitis | University of Jordan | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bone Bioactive Liquid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06587880 ↗ |
| Known as | BBL | “Bone Bioactive Liquid (BBL) mouthwash” NCT06587880 ↗ |
| Route | Oral | “Bone bioactive liquid (BBL) is a saline solution used as a mouthwash” NCT06587880 ↗ |